+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07067749

Phase III Study Evaluating MRI-Based Treatment Pathway for Muscle-Invasive Bladder Cancer Compared to Standard Surgery

Led by University of Rome Tor Vergata · Updated on 2025-07-24

92

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new diagnostic and treatment approach for muscle-invasive bladder cancer MIBC in a phase III randomized trial called TEMPO-MIBC. This study compares a standard treatment pathway involving surgical tumor resection with an experimental approach using multiparametric bladder MRI mpMRI to speed up care. The goal is to reduce the time to definitive treatment and possibly improve long-term cancer outcomes by avoiding some surgical procedures when mpMRI confirms muscle invasion. Participants are randomly assigned to one of two groups. The experimental group receives a bladder mpMRI to confirm muscle invasion and may skip the standard transurethral resection of bladder tumor TURBt surgery, moving directly to the next treatment step. The control group undergoes standard care with flexible cystoscopy, bladder biopsy, and TURBt surgery for staging. Both groups have their cases reviewed by a multidisciplinary board to decide on the best treatment, which is scheduled after shared decision-making with the patient. During the study, blood samples will be collected at three time points to measure circulating tumor DNA ctDNA, which reflects tumor burden and treatment response. Researchers will track the time from enrollment to definitive treatment, cancer-specific and overall survival, time to recurrence, and procedure-related complications. Monitoring will continue for about two years to assess outcomes and safety. The study begins with baseline assessments and follows patients through their treatment and recovery periods.

CONDITIONS

Brief Title

Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

Research Team

S

Simone Albisinni, MD, Phd, FEBU

L

Luca Orecchia, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here